Malignant melanoma in the Czech Republic: Incidence and mortality according to sex, age and disease stage

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F14%3A33152285" target="_blank" >RIV/61989592:15110/14:33152285 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/14:10293069 RIV/00216208:11120/14:43907710 RIV/00064173:_____/14:#0000433 RIV/68407700:21460/14:00202590

Výsledek na webu

<a href="http://dx.doi.org/10.5507/bp.2012.081" target="_blank" >http://dx.doi.org/10.5507/bp.2012.081</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5507/bp.2012.081" target="_blank" >10.5507/bp.2012.081</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Malignant melanoma in the Czech Republic: Incidence and mortality according to sex, age and disease stage

Popis výsledku v původním jazyce

Background. The Czech Republic has reported one of the highest incidence rates of cutaneous melanoma (CM) in Europe and the rate continues to rise. Our study undertook a detailed investigation of the incidence and mortality of melanoma relative to sex, age and disease stage. The main goals were to elucidate the causes of the rising trends and explain the differences in development relative to sex, age and disease stage. Methods and Results. The estimated annual percentage change (EAPC) using the Joinpoint Regression Model was calculated separately for men and women for all age categories and for all T stages of TNM classification. The EAPC for women was slightly higher than for men. This was only found in melanomas thinner than 1 mm (T1). For all otherstages (T2, T3 and T4) the situation was worse in men. A higher incidence rate of CM and the higher value of EAPC were found for women in younger age categories (up to 49 years). In the next age category, from 50 to 59 years, the inciden

Název v anglickém jazyce

Malignant melanoma in the Czech Republic: Incidence and mortality according to sex, age and disease stage

Popis výsledku anglicky

Background. The Czech Republic has reported one of the highest incidence rates of cutaneous melanoma (CM) in Europe and the rate continues to rise. Our study undertook a detailed investigation of the incidence and mortality of melanoma relative to sex, age and disease stage. The main goals were to elucidate the causes of the rising trends and explain the differences in development relative to sex, age and disease stage. Methods and Results. The estimated annual percentage change (EAPC) using the Joinpoint Regression Model was calculated separately for men and women for all age categories and for all T stages of TNM classification. The EAPC for women was slightly higher than for men. This was only found in melanomas thinner than 1 mm (T1). For all otherstages (T2, T3 and T4) the situation was worse in men. A higher incidence rate of CM and the higher value of EAPC were found for women in younger age categories (up to 49 years). In the next age category, from 50 to 59 years, the inciden

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

<a href="/cs/project/ED0030%2F01%2F01" target="_blank" >ED0030/01/01: Biomedicína pro regionální rozvoj a lidské zdroje</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Biomedical Papers-Olomouc

ISSN

1213-8118

e-ISSN

—

Svazek periodika

158

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

9

Strana od-do

438-446

Kód UT WoS článku

000345398500017

EID výsledku v databázi Scopus

—